00673.HK
China Health Group Limited
HKSE · Healthcare · Medical - Distribution · HK
HKD 0.29
−6.45%Year over year
Reported trailing growth
- Revenue
- +5.5%
- EBITDA
- +31.8%
- EBIT
- +32.3%
- EPS
- +58.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -18.7%
- EBITDA
- +32.0%
- EBIT
- +32.3%
- Net income
- +29.3%
- EPS
- +64.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026